KSP inhibitor SB743921 induces death of multiple myeloma cells via inhibition of the NF-κB signaling pathway - Song, In-Sung; Jeong, Yu Jeong; Nyamaa, Bayalagmaa; Jeong, Seung Hun; Kim, Hyoung Kyu; Kim, Nari; Ko, Kyung Soo; Rhee, Byoung Doo; Han, Jin (BMB reports, 2015)
Keywords: Antineoplastic Combined Chemotherapy Protocols - pharmacology; Apoptosis - drug effects; Benzamides - administration & dosage; Benzamides - pharmacology; Bortezomib - administration & dosage; Bortezomib - pharmacology; Cell Cycle Checkpoints - drug effects; Cell Line, Tumor; Chromones - administration & dosage; Chromones - pharmacology; Drug Resistance, Neoplasm; Drug Synergism; Humans; Kinesin - antagonists & inhibitors; Kinesin - metabolism; Mitochondria - metabolism; Multiple Myeloma - drug therapy; Multiple Myeloma - metabolism; Multiple Myeloma - pathology; NF-kappa B - antagonists & inhibitors; NF-kappa B - metabolism; Signal Transduction - drug effects; 화학